[1]
Barnes M.P..: An overview of the clinical management of spasticity. In:
Barnes M.P., Johnson GR (eds). Upper motor syndrome and spasticity:
Clinical management and neurophysiology. Cambridge University Press,
2001; 1-11.
[2]
Konturek S.: Fizjologia człowieka. T. IV. Neurofizjologia. Wydawnictwo
Uniwersytetu Jagiellońskiego, 1998.
[3]
Traczyk W.Z.: Fizjologia człowieka w zarysie. PZWL, 2000.
[4]
Schneider S.P., Fyffe R.E.: Involvement of GABA and glycine in recurrent
inhibition of spinal motoneurons. J Neurophysiol 1992; 68(2): 397-406.
[5]
Ganong W.F.: Fizjologia. Podstawy fizjologii lekarskiej. PZWL, 1994.
[6]
Lance J.W.: Spasticity: disordered motor control. In: Feldman R.G.,
Young R.R., Koella W.P. (eds.) Symposium synopsis. Yearbook Medical
1980.
[7]
Salazar-Torres Jde J. et al.: Does spasticity result from hyperactive stretch
reflexes? Preliminary findings from a stretch reflex characterization
study. Disabil Rehabil 2004 Jun; 17, 26(12): 756-760.
[8]
Pandyan A.D. et al.: Spasticity: Clinical perceptions, neurological realities
and meaningful measurement. Disability and Rehabilitation 2005; 27
(1/2): 2-6.
[9]
Mayer N.H.: Clinicophysiologic concepts of spasticity and motor
dysfunction in adults with an upper motoneuron lesion. Muscle & Nerve
1997 (suppl 6); 1-13.
[10]
Sandrini G. et al.: The lower limb flexion reflex in humans. Prog Neurobiol
2005 Dec; 77(6): 353-395.
[11]
Rushworth G.: Some pathophysiological aspects of spasticity and the
search for rational and successful therapy. Int Rehabil Med 1980; 2(1):
23-26.
[12]
Voerman G.E., Hermens H.J.: Neurophysiological methods for the
assessment of spasticity-The Hoffmann reflex, the Tendon reflex and the
Stretch reflex. Disability and Rehabilitation 2005; 1/2 (27): 33-68.
[13]
Haselkorn J.K., Loomis S.: Multiple sclerosis and spasticity. Phys Med
Rehabil Clin N Am 2005 May; 16(2): 467-481.
[14]
Brown P.: Pathophysiology of spasticity. J Neurol Nerosurg Psychiatry
1994; 57: 773-777.
[15]
Hufschmidt A., Mauritz K.H.: Chronic transformation of muscle in
spasticity: a peripheral contribution to increased tone. J Neurol
Neurosurg Psychiatry 1985; 48: 676-685.
[16]
Gracies J.M.: Pathophysiology of spastic paresis I. Paresis and softtissue
changes. Muscle Nerve 2005; 31: 535-551.
[17]
Lakie M., Robson L.G.: Thixotropic changes in human muscle stiffness
and the effects of fatigue. Q J Exp Physiol 1988; 73: 487-500.
[18]
Platz T. et al.: Clinical scales for the assessment of spasticity, associated
phenomena, and function: a systematic review of the literature. Disabil
Rehabil 2005; 27(1/2): 7-18.
[19]
Ashworth B.: Preliminary trial of carisoprodol in multiple sclerosis.
Practitioner 1964; 192 (0031-6518): 540-542.
[20]
Bohannon R.W., Smith M.B.: Interrater of a modiefed Ashworth Scale of
muscle spasticity. Phys Ther 1986; 67: 206-207.
[21]
Tardieu G. et al.: A la d’une techique de mesure de la spasticité. In: Held
J.P. Pierrot-Deseilligny E. (eds): Rééducation Motrice des Affections
Neurologiques. JB Baillere et Fils, Paris 1969; 31-42.
[22]
Mehrholz J. et al.: Reliability of the Modified Tardieu Scale and the
Modified Ashworth Scale in adult patients with severe brain injury: a
comparison study. Clin Rehabil 2005; 19(7): 751-759.
[23]
Snow B.J. et al.: Treatment of spasticity with botulinum toxin: a doubleblind
study. Ann Neurol 1990; 28(4): 512-515.
[24]
Penn R.D. et al.: Intrathecal baclofen for severe spinal spasticity. N Engl
J Med. 1989 Jun; 8, 320(23): 1517-1521.
[25]
Drozdowski W.: Elektrofizjologiczne metody oceny spastyczności.
Postępy Psychiatrii i Neurologii 2004; 13, 2 (18); 7-11.
[26]
Hilgevoord A.A., Bour L.J., Koelman J.H., Ongerboer de Visser B.W.:
Soleus H reflex extinction in controls and spastic patients: ordered
occlusion or diffuse inhibition? Electroencephalogr Clin Neurophysiol
1995 Dec; 97(6): 402-407.
[27]
Stokic D.S. et al.: Comparison of clinical and neurophysiologic responses
to intrathecal baclofen bolus administration in moderate-to-severe
spasticity after acquired brain injury. Arch Phys Med Rehabil 2005 Sep;
86(9): 1801-1806.
[28]
Gildenberg P.L. et al.: Characteristics of the tonic stretch reflex in spastic
spinal cord and head-injured patients. Appl Neurophysiol 1985; 48(1-6):
106-110.
[29]
Nardone A., Schieppati M.: Reflex contribution of spindle group Ia and II
afferent input to leg muscle spasticity as revealed by tendon vibration in
hemiparesis. Clin Neurophysiol 2005 Jun; 116(6): 1370-1381.
[30]
Keenan M.A. et al.: The use of dynamic electromyography to evaluate
motor control in the hands of adults who have spasticity caused by brain
injury. J Bone Joint Surg Am 1989 Jan; 71(1): 120-126.
[31]
Bajd T., Vodovnik L.: Pendulum testing of spasticity. J Biomed Eng 1984;
6(1): 9-16.
[32]
Firoozbakhsh K.K. et al.: Isokinetic dynamometric technique for spasticity
assessment. Am J Phys Med Rehabil 1993 Dec; 72(6): 379-385.
[33]
Syczewska M., Lebiedowska M.K., Pandyan A.D.: Quantifying
repeatability of the Wartenberg pendulum test parameters in children
with spasticity. J Neurosci Methods 2009; 15,178(2): 340-344.
[34]
Franek A. et al.: Goniometryczny test wahadła w spastyczności. Postępy
Psychiatrii i Neurologii 2004; 13, (suppl 20): 17-21.
[35]
Krawczyk M. et al.: Wybrane problemy badania i fizjoterapii chorych ze
spastycznością. Postępy Psychiatrii i Neurologii 2004; 13, suppl 2 (18):
23-28.
[36]
Pierson S.H.: Outcome measures in spasticity management. Muscle & Nerve 1997 (suppl. 6); 1-25.
[37]
Kleissen R.F.M. et al.: Long-term ambulatory recording of surface EMG in
the assessment of spasticity. Electromyogr Kinesiol 1991; 435-438.
[38]
Voerman G.E. et al.: Towards remote long-term monitoring of spasticity.
In: http://awareness.freeband.nl
[39]
Buffenoir K. et al.: Interest of peripheral anesthetic blocks as a diagnosis
and prognosis tool in patients with spastic equinus foot: a clinical and
electrophysiological study of the effects of block of nerve branches to the
triceps surae muscle. Clin Neurophysiol 2005 Jul; 116(7): 1596-1600.
[40]
Kiwerski J.: Schorzenia i urazy kręgosłupa. PZWL, Warszawa 2001.
[41]
Rodda J., Graham H.K.: Classification of gait patterns in spastic
hemiplegia and spastic diplegia: a basis for a management algorithm.
Eur J Neurol 2001 Nov; 8 (suppl 5): 98-108.
[42]
Francis H.P. et al.: Does reducing spasticity translate into functional
benefit? An exploratory meta-analysis. J Neurol Neurosurg Psychiatry
2004; 75: 1547-1551.
[43]
Glenn M.B., Whyte J.: The Practical Management of Spasticity in
Children and Adults. Lea & Febiger, Philadelphia 1990.
[44]
Ochs G.A., Reimann I.W.: Baclofen Intrathekal. Leitfaden fuer die
praktische Anwendung. Georg Thieme Verlag, Stuttgart 1995.
[45]
Hallenborg S.C. et al.: The Practical Management of Spasticity in Children
and Adults. Lea & Febiger, Philadelphia 1990, 97-117.
[46]
Głowacka J., Krawczyk M.: Zaburzenia napięcia mięśniowego i ich
wpływ na stan funkcjonalny w grupie pacjentów we wczesnym okresie
po udarze mózgu. Fizjoter Pol 2005; 5(1): 48-56.
[47]
Krawczyk M., Sidaway M.: Kliniczne efekty intensywnego leczenia
ruchem pacjentów po przebytym udarze mózgu. Neurol Neurochir Pol
2002; suppl 1: 41-60.
[48]
Kwolek A. Rehabilitacja medyczna. T. II. Urban & Partner, 2003.
[49]
Gollhofer A. et al.: Changes in reflex excitability following isometric
contraction in humans. Eur J Appl Physiol Occup Physiol 1998; 77(1-2):
89-97.
[50]
Nowotny J.: Rehabilitacja ruchowa w neurogennych dysfunkcjach
narządu ruchu u dzieci. [W:] Milanowska K. (red.): Podstawy rehabilitacji
ruchowej - tom I. Sport i Turystyka, Warszawa 1981.
[51]
S. Lennon S., Hastins M.: Główne fizjoterapeutyczne wskaźniki jakości
opieki nad chorymi po udarach mózgu. Rehabilitacja Medyczna 1997; 2:
27-37.
[52]
Giebler K.: Physical Modalities. In: Glenn M., Whyte J. (eds.) The
Practical Management of Spasticity in Children and Adults. Lea & Febiger, Philadelphia 1990; 118–148.
[53]
Bell K.R., Lehmann J.F.: Effect of cooling on H- and T-reflexes in normal
subjects. Arch Phys Med Rehabil 1987; 68: 490-493.
[54]
Douglas W.W., Malcolm J.L.Ł: The effect of localized cooling on
conduction in cat nerves. J Physiol 1995; 130: 53-71.
[55]
Allison S.C., Abraham L.D.: Sensitivity of qualitative and quantitative
spasticity measures to clinical treatment with cryotherapy. Int J Rehabil
Res 2001; 24(1): 15-24.
[56]
Kwolek A. et al.: Cryotherapy of the hand in patients with spastic paresis
after stroke. Advances in Rehabilitation 2005, (1); 55-59.
[57]
Gracies J.M.: Physical modalities other than stretch in spastic hypertonia.
Phys Med Rehabil Clin N Am 2001; 12(4): 769-792.
[58]
Aydin G. et al.: Transcutaneous electrical nerve stimulation versus
baclofen in spasticity: clinical and electrophysiologic comparison. Am J
Phys Med Rehabil 2005 Aug; 84(8): 584-592.
[59]
Yan T. et al.: Functional electrical stimulation improves motor recovery
of the lower extremity and walking ability of subjects with first acute
stroke: a randomized placebo-controlled trial. Stroke 2005 Jan; 36(1):
80-87.
[60]
Dziedzic S., Straburzyńska-Lupa A.: Możliwości zabiegów fizykalnych w
leczeniu spastyczności. Fizjoter Pol 2004; 4(3): 250-253.
[61]
Selles R.W. et al.: Feedback-controlled and programmed stretching of
the ankle plantarflexors and dorsiflexors in stroke: effects of a 4-week
intervention program. Arch Phys Med Rehabil 2005; 86(12): 2330-
2336.
[62]
Kesiktas N. et al.: The use of hydrotherapy for the management of
spasticity. Neurorehabil Neural Repair 2004; 18(4): 268-273.
[63]
Giebler K.: Physical Modalities. [In:] Glenn M., Whyte J. (eds.): The
Practical Management of Spasticity in Children and Adults. Lea & Febiger, Philadelphia. 1990; 118-148.
[64]
Krause P., Straube A.: Reduction of spastic tone increase induced by
peripheral repetitive magnetic stimulation is frequency-independent.
NeuroRehabilitation 2005; 20(1): 63-65.
[65]
Marsden C.D.: Treating Spasticity: Pharmacological Advances. Hans
Huber Publishers, 1989.
[66]
Kamensek J.: Continuous intrathecal baclofen infusions. An introduction
and overview. Axone 1999; 20(4): 93-98.
[67]
Jóźwiak M. et al.: Intrathecal baclofen for treatment of spasticity in
patient with cerebral palsy - a preliminary report. Chir Narządów Ruchu
Ortop Pol 2003; 68(4): 253-259.
[68]
Rychlewski J.: Dokanałowe podawanie baklofenu - metoda z wyboru w
leczeniu spastyczności. Ortop Traumatol Rehab 2002; 4 (1): 57-59.
[69]
Jarrett L. et al.: Managing severe lower limb spasticity in multiple
sclerosis: does intrathecal phenol have a role? J Neurol Neurosurg
Psychiatry 2002; 73(6): 705-709.
[70]
Iwatsubo E. et al.: Selective intrathecal phenol block to improve activities
of daily living in patients with spastic quadriplegia. A preliminary report.
Paraplegia 1994 Jul; 32(7): 489-492.
[71]
Barnes M.: Botulinum toxin-mechanisms of action and clinical use in
spasticity. J Rehabil Med 2003; (suppl 41): 56-59.
[72]
Gough M. et al.: Botulinum toxin and cerebral palsy: time for reflection?
Dev Med Child Neurol 2005; 47(10): 709-712.
[73]
Członkowski A., Mirowska D.: Farmakoterapia spastyczności. Ortop
Traumatol Rehab 2002; 4 (1): 54-56.
[74]
Henry G., Chambers M.D.: The surgical Treatment of Spasticity. Muscle
Nerve 1997; 20 (suppl 6): 122.
[75]
Nishida T. et al.: Selective posterior rhizotomy for children with cerebral
palsy: a 7-year experience. Childs Nerv Syst 1995; 11(7): 374-380.
[76]
Sindou M.: Microsurgical DREZotomy (MDT) for pain, spasticity, and
hyperactive bladder: a 20-year experience. Acta Neurochir (Wien) 1995;
137(1-2): 1-5.
[77]
Harat M., Rudaś M.: Metody chirurgicznego leczenia spastyczności.
Neurol Neurochir Pol 2002; 36 (3): 539-552.
[78]
Davis R.: Cerebellar stimulation for cerebral palsy spasticity, function,
and seizures. Arch Med Res 2000; 31(3): 290-299.
Scholar Google
PubMed